(Q35116219)

6 August 2017

1 reference

title

Bcl-2 and apoptosis in chronic lymphocytic leukemia (English)

1 reference

6 August 2017

0 references

1 reference

Aaron D Schimmer

1

1 reference

6 August 2017

Irene Munk-Pedersen

series ordinal

2

1 reference

6 August 2017

Mark D Minden

series ordinal

3

1 reference

6 August 2017

John C Reed

series ordinal

4

1 reference

6 August 2017

1 June 2003

1 reference

Current Treatment Options in Oncology

6 August 2017

1 reference

6 August 2017

4

1 reference

6 August 2017

211-218

1 reference

6 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-003-0022-y

6 August 2017

0 references

cites work

Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia

1 reference

12 December 2020

The triterpenoid CDDO induces apoptosis in refractory CLL B cells

1 reference

12 December 2020

Inhibition of Akt and its anti-apoptotic activities by tumor necrosis factor-induced protein kinase C-related kinase 2 (PRK2) cleavage

1 reference

12 December 2020

Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.

1 reference

12 December 2020

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

1 reference

12 December 2020

Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells

1 reference

12 December 2020

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

1 reference

12 December 2020

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).

1 reference

12 December 2020

Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer

1 reference

12 December 2020

Primitive human hematopoietic precursors express Bcl-x but not Bcl-2

1 reference

12 December 2020

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

12 December 2020

Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view

1 reference

12 December 2020

Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia

1 reference

12 December 2020

Increased bcl-2/bax ratio in B-cell chronic lymphocytic leukemia is associated with a progressive pattern of disease

1 reference

12 December 2020

Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations

1 reference

12 December 2020

Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia

1 reference

12 December 2020

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

12 December 2020

A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer.

1 reference

12 December 2020

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

12 December 2020

The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma

1 reference

12 December 2020

Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.

1 reference

12 December 2020

Bcl-2 family: life-or-death switch

1 reference

12 December 2020

Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome

1 reference

12 December 2020

Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells

1 reference

12 December 2020

Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells

1 reference

12 December 2020

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.

1 reference

12 December 2020

10.1007/S11864-003-0022-Y

Identifiers

DOI

1 reference

6 August 2017

1 reference